Additionally, changes in Alzheimer’s disease biomarkers, such as beta-amyloid (Aβ) deposition, tau phosphorylation, cortical thickness, or brain glucose metabolism, can occur 10–20 years before the clinical symptoms of AD appear (Vassilaki et al., 2018). Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.